The tweet was deleted by the author.
But we saved everything 🙂.
Danny Naz, industry influencer, reports that several high beta biotech stocks have received positive initial ratings from major firms.
Baird initiated coverage of LYEL with an Outperform rating, Rothschild started APGE with a Buy, and JPM issued an Overweight on ARWR.
Naz has previously tracked notable equity moves, citing Alcoa’s persistent climb above $64–$65 in recent trading due to strong flow and breakout strength in a recent article. He has also highlighted that detailed analysis of market drivers for 2026 is available through subscription to The Edge Lab service. These updates reflect his ongoing coverage of activity in high-momentum sectors.